Clozapine Therapy and CYP Genotype

Dean L, Kane M.

2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

α-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1.

Desplats P, Spencer B, Crews L, Pathel P, Morvinski-Friedmann D, Kosberg K, Roberts S, Patrick C, Winner B, Winkler J, Masliah E.

J Biol Chem. 2012 Sep 14;287(38):31691-702. doi: 10.1074/jbc.M112.354522.

NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Martinez-Fong D, Bannon MJ, Trudeau LE, Gonzalez-Barrios JA, Arango-Rodriguez ML, Hernandez-Chan NG, Reyes-Corona D, Armendáriz-Borunda J, Navarro-Quiroga I.

Nanomedicine. 2012 Oct;8(7):1052-69. doi: 10.1016/j.nano.2012.02.009. Review.

The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism.

Kumar H, Lim HW, More SV, Kim BW, Koppula S, Kim IS, Choi DK.

Int J Mol Sci. 2012;13(8):10478-504. doi: 10.3390/ijms130810478. Review.

Α-synuclein misfolding and Parkinson's disease.

Breydo L, Wu JW, Uversky VN.

Biochim Biophys Acta. 2012 Feb;1822(2):261-85. doi: 10.1016/j.bbadis.2011.10.002. Review.

Dementia is associated with insulin resistance in patients with Parkinson's disease.

Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, De Bartolo M, Mungari P, Fonte G, Consoli D, Consoli A, Fava A.

J Neurol Sci. 2012 Apr 15;315(1-2):39-43. doi: 10.1016/j.jns.2011.12.008.

The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease.

Sourani D, Eitan R, Gordon N, Goelman G.

Eur J Neurosci. 2012 Sep;36(6):2822-9. doi: 10.1111/j.1460-9568.2012.08200.x.

Altered perceptual sensitivity to kinematic invariants in Parkinson's disease.

Dayan E, Inzelberg R, Flash T.

PLoS One. 2012;7(2):e30369. doi: 10.1371/journal.pone.0030369.

Downregulation of Pael-R expression in a Parkinson's disease cell model reduces apoptosis.

Zou T, Xiao B, Tang J, Zhang H, Tang X.

J Clin Neurosci. 2012 Oct;19(10):1433-6. doi: 10.1016/j.jocn.2011.12.024.

The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease.

Ratzka A, Kalve I, Özer M, Nobre A, Wesemann M, Jungnickel J, Köster-Patzlaff C, Baron O, Grothe C.

Cell Transplant. 2012;21(4):749-62. doi: 10.3727/096368911X586774.

Glutathione s-transferase omega 1 activity is sufficient to suppress neurodegeneration in a Drosophila model of Parkinson disease.

Kim K, Kim SH, Kim J, Kim H, Yim J.

J Biol Chem. 2012 Feb 24;287(9):6628-41. doi: 10.1074/jbc.M111.291179.

Characterizing the spiking dynamics of subthalamic nucleus neurons in Parkinson's disease using generalized linear models.

Eden UT, Gale JT, Amirnovin R, Eskandar EN.

Front Integr Neurosci. 2012 Jun 20;6:28. doi: 10.3389/fnint.2012.00028.

The cortical and striatal gene expression profile of 100 hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model.

Huo LR, Liang XB, Li B, Liang JT, He Y, Jia YJ, Jia J, Gong XL, Yu F, Wang XM.

Evid Based Complement Alternat Med. 2012;2012:908439. doi: 10.1155/2012/908439.

What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?

Hagikura M, Iwamoto K, Aleksic B, Ozaki N.

Psychiatry Clin Neurosci. 2012 Aug;66(5):463. doi: 10.1111/j.1440-1819.2012.02362.x. No abstract available.

Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.

Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH.

Mov Disord. 2012 May;27(6):709-15. doi: 10.1002/mds.23838.